The latest funding round was led by Korean venture capital firm Luha Private Equity and included participation from existing investors KB Investment and Quad Investment Management. The company said it will use the funds to expand its global operations and develop new techniques aimed at enabling accurate analysis of cells in their native state.

Curiox currently offers Laminar Wash, a methodology designed to facilitate life science research and product development by standardizing manual cell preparation.

Curiox joins NIST Flow Cytometry Standards Consortium
Curiox Biosystems has become a member of the National Institute of Standards and Technology (NIST) Flow Cytometry Standards Consortium.